2013 Q3 Form 10-Q Financial Statement
#000110465913059323 Filed on August 02, 2013
Income Statement
Concept | 2013 Q3 | 2013 Q2 | 2012 Q2 |
---|---|---|---|
Revenue | $629.0K | $1.152M | $923.0K |
YoY Change | -6.68% | 24.81% | 383.25% |
Cost Of Revenue | $459.0K | $1.196M | $437.0K |
YoY Change | 45.25% | 173.68% | |
Gross Profit | $170.0K | -$44.00K | $486.0K |
YoY Change | -52.51% | -109.05% | 155.79% |
Gross Profit Margin | 27.03% | -3.82% | 52.65% |
Selling, General & Admin | $2.995M | $3.422M | $3.437M |
YoY Change | -5.52% | -0.44% | -18.09% |
% of Gross Profit | 1761.76% | 707.2% | |
Research & Development | $4.520M | $4.830M | $5.010M |
YoY Change | -8.32% | -3.59% | -16.5% |
% of Gross Profit | 2658.82% | 1030.86% | |
Depreciation & Amortization | $210.0K | $230.0K | $340.0K |
YoY Change | -32.26% | -32.35% | -12.82% |
% of Gross Profit | 123.53% | 69.96% | |
Operating Expenses | $2.995M | $3.422M | $3.437M |
YoY Change | -5.52% | -0.44% | -18.09% |
Operating Profit | -$6.498M | -$7.348M | -$7.957M |
YoY Change | -16.08% | -7.65% | -20.47% |
Interest Expense | $40.00K | $12.00K | $34.00K |
YoY Change | 48.15% | -64.71% | 47.83% |
% of Operating Profit | |||
Other Income/Expense, Net | -$9.000K | -$9.000K | $9.000K |
YoY Change | 350.0% | -200.0% | |
Pretax Income | -$6.720M | -$7.090M | -$7.950M |
YoY Change | -13.29% | -10.82% | -20.34% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$7.250M | -$7.870M | -$7.950M |
YoY Change | -6.45% | -1.01% | -20.34% |
Net Earnings / Revenue | -1152.62% | -683.16% | -861.32% |
Basic Earnings Per Share | -$0.21 | -$0.23 | -$0.23 |
Diluted Earnings Per Share | -$0.21 | -$0.23 | -$0.23 |
COMMON SHARES | |||
Basic Shares Outstanding | 34.52M shares | 34.43M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2013 Q3 | 2013 Q2 | 2012 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $25.70M | $31.70M | $48.20M |
YoY Change | -46.23% | -34.23% | -36.99% |
Cash & Equivalents | $8.872M | $11.91M | $12.13M |
Short-Term Investments | $16.90M | $19.80M | $36.00M |
Other Short-Term Assets | $900.0K | $900.0K | $600.0K |
YoY Change | 28.57% | 50.0% | 0.0% |
Inventory | $3.400M | $3.196M | $2.821M |
Prepaid Expenses | |||
Receivables | $501.0K | $336.0K | $1.000M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $30.94M | $36.91M | $52.60M |
YoY Change | -41.48% | -29.82% | -32.3% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $891.0K | $1.087M | $1.800M |
YoY Change | -45.47% | -39.61% | -28.0% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $0.00 | $11.80M | |
YoY Change | -100.0% | -36.9% | |
Other Assets | $50.00K | $95.00K | $700.0K |
YoY Change | -47.37% | -86.43% | 0.0% |
Total Long-Term Assets | $1.560M | $1.801M | $14.33M |
YoY Change | -80.72% | -87.43% | -34.25% |
TOTAL ASSETS | |||
Total Short-Term Assets | $30.94M | $36.91M | $52.60M |
Total Long-Term Assets | $1.560M | $1.801M | $14.33M |
Total Assets | $32.50M | $38.71M | $66.93M |
YoY Change | -46.69% | -42.16% | -32.73% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $422.0K | $102.0K | $600.0K |
YoY Change | 75.83% | -83.0% | 0.0% |
Accrued Expenses | $3.190M | $3.211M | $2.926M |
YoY Change | -8.86% | 9.74% | -13.94% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $4.300M | $3.980M | $4.000M |
YoY Change | -11.38% | -0.5% | -35.48% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $137.0K | $300.0K |
YoY Change | -100.0% | -54.33% | -99.19% |
Total Long-Term Liabilities | $0.00 | $137.0K | $300.0K |
YoY Change | -100.0% | -54.33% | -99.19% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.300M | $3.980M | $4.000M |
Total Long-Term Liabilities | $0.00 | $137.0K | $300.0K |
Total Liabilities | $4.300M | $4.117M | $4.262M |
YoY Change | -15.3% | -3.4% | -90.16% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$263.9M | -$256.7M | |
YoY Change | 13.5% | ||
Common Stock | $292.2M | $291.3M | |
YoY Change | 1.3% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $28.20M | $34.60M | $62.67M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $32.50M | $38.71M | $66.93M |
YoY Change | -46.69% | -42.16% | -32.73% |
Cashflow Statement
Concept | 2013 Q3 | 2013 Q2 | 2012 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$7.250M | -$7.870M | -$7.950M |
YoY Change | -6.45% | -1.01% | -20.34% |
Depreciation, Depletion And Amortization | $210.0K | $230.0K | $340.0K |
YoY Change | -32.26% | -32.35% | -12.82% |
Cash From Operating Activities | -$5.920M | -$5.790M | -$5.880M |
YoY Change | -5.73% | -1.53% | -1.01% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$10.00K | -$210.0K | -$140.0K |
YoY Change | -90.91% | 50.0% | -17.65% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $2.900M | -$2.610M | $8.550M |
YoY Change | -75.13% | -130.53% | -119.65% |
Cash From Investing Activities | $2.890M | -$2.810M | $8.420M |
YoY Change | -74.98% | -133.37% | -119.27% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 0.000 | 10.00K |
YoY Change | -100.0% | -99.98% | |
NET CHANGE | |||
Cash From Operating Activities | -5.920M | -5.790M | -5.880M |
Cash From Investing Activities | 2.890M | -2.810M | 8.420M |
Cash From Financing Activities | 0.000 | 0.000 | 10.00K |
Net Change In Cash | -3.030M | -8.600M | 2.550M |
YoY Change | -157.5% | -437.25% | -1044.44% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$5.920M | -$5.790M | -$5.880M |
Capital Expenditures | -$10.00K | -$210.0K | -$140.0K |
Free Cash Flow | -$5.910M | -$5.580M | -$5.740M |
YoY Change | -4.21% | -2.79% | -0.52% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013Q2 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
31678000 | USD |
mblx |
Minimum Period For Which Cash Cash Equivalents Investments And Cash From Expected Product Sales Is Sufficient To Meet Projected Operating Requirements
MinimumPeriodForWhichCashCashEquivalentsInvestmentsAndCashFromExpectedProductSalesIsSufficientToMeetProjectedOperatingRequirements
|
P12M | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 26pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></p> <p style="TEXT-INDENT: 26pt; MARGIN: 0in 0in 0pt;"> </p> </div> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Concentration of Credit Risk</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash and cash equivalents and short-term investments. The Company primarily invests its excess cash and cash equivalents in money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments are acquired in accordance with the Company’s investment policy which establishes a concentration limit per issuer.</font></p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 27pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company provides credit to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary. At June 30, 2013, the Company’s accounts and unbilled receivables include $724 or 63% from U.S. and Canadian government grants and $315 or 27% from customer product sales. At December 31, 2012, the Company’s accounts and unbilled receivables included $561 or 46% from U.S. and Canadian government grants and $535 or 44% from customer product sales. At June 30, 2013, no customer had accounts receivable due from product sales of 10% or greater, and December 31, 2012, one customer represented 41%, of accounts receivable due from product sales.</font></p> <p style="MARGIN: 0in 0in 0pt;"> </p> </div> | ||
us-gaap |
Dilutive Securities
DilutiveSecurities
|
0 | USD | |
CY2013Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7866000 | USD |
CY2012Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7948000 | USD |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-14628000 | USD | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
20892000 | USD | |
CY2013Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
34434271 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
34393998 | shares | |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
104410 | shares | |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
104410 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
34264428 | shares | |
CY2013Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5647604 | shares |
CY2012Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4460713 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5539962 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4440713 | shares | |
CY2013Q2 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
674000 | USD |
CY2013Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
2522000 | USD |
CY2013Q2 | us-gaap |
Inventory Net
InventoryNet
|
3196000 | USD |
CY2012Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
640000 | USD |
CY2012Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
2000 | USD |
CY2012Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
2562000 | USD |
CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
3204000 | USD |
CY2013Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
163000 | USD |
CY2012Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
257000 | USD |
CY2012Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
31696000 | USD |
CY2012Q4 | us-gaap |
Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
|
13000 | USD |
CY2012Q4 | us-gaap |
Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
|
31709000 | USD |
CY2013Q2 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
19768000 | USD |
CY2013Q2 | us-gaap |
Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
|
3000 | USD |
CY2013Q2 | us-gaap |
Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
|
19770000 | USD |
mblx |
Long Term Investments Maximum Maturity Period
LongTermInvestmentsMaximumMaturityPeriod
|
P2Y | ||
mblx |
Available For Sale Securities Average Maturity
AvailableForSaleSecuritiesAverageMaturity
|
P3M | ||
CY2012 | mblx |
Available For Sale Securities Average Maturity
AvailableForSaleSecuritiesAverageMaturity
|
P4M | |
CY2013Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1695000 | USD |
CY2013Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
436000 | USD |
CY2013Q2 | mblx |
Accrued Intellectual Property Current
AccruedIntellectualPropertyCurrent
|
163000 | USD |
CY2013Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
917000 | USD |
CY2013Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3211000 | USD |
CY2012Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2379000 | USD |
CY2012Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
301000 | USD |
CY2012Q4 | mblx |
Accrued Intellectual Property Current
AccruedIntellectualPropertyCurrent
|
105000 | USD |
CY2012Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
734000 | USD |
CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3519000 | USD |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | ||
us-gaap |
Inventory Write Down
InventoryWriteDown
|
271000 | USD | |
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | item | |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
3648000 | USD | |
us-gaap |
Segment Reporting Information Revenue
SegmentReportingInformationRevenue
|
3648000 | USD | |
CY2013Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1706000 | USD |
CY2013Q2 | us-gaap |
Segment Reporting Information Revenue
SegmentReportingInformationRevenue
|
1706000 | USD |
CY2012Q2 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
923000 | USD |
CY2012Q2 | us-gaap |
Segment Reporting Information Revenue
SegmentReportingInformationRevenue
|
923000 | USD |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
40245000 | USD | |
us-gaap |
Segment Reporting Information Revenue
SegmentReportingInformationRevenue
|
40245000 | USD | |
CY2013Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
814000 | USD |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1677000 | USD | |
CY2012Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
980000 | USD |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2102000 | USD | |
CY2013Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
4714000 | USD |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y3M | ||
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5579042 | shares |
CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6173843 | shares |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
903915 | shares | |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
7550 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
127693 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
173871 | shares | |
CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
3458023 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.68 | |
CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.91 | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
1.67 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.82 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
3.69 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
10.09 | ||
CY2013Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
8.28 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.18 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0071 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0067 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0149 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0115 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.84 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.85 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.87 | pure | |
CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1358000 | USD |
CY2013Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1087000 | USD |
CY2013Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2012Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2013Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | USD |
CY2012Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | USD |
CY2012Q4 | mblx |
Operating Loss Carryforwards Attributable To Deduction Related To Exercise Of Stock Options
OperatingLossCarryforwardsAttributableToDeductionRelatedToExerciseOfStockOptions
|
19213000 | USD |
mblx |
Maximum Period To Audit For Loss
MaximumPeriodToAuditForLoss
|
P3Y | ||
mblx |
Provision For Income Taxes For Undistributed Earnings Of Foreign Subsidiaries
ProvisionForIncomeTaxesForUndistributedEarningsOfForeignSubsidiaries
|
0 | USD | |
CY2012Q4 | us-gaap |
Assets
Assets
|
53510000 | USD |
mblx |
Revenue From Termination Of Collaboration With Subsidiary
RevenueFromTerminationOfCollaborationWithSubsidiary
|
38885000 | USD | |
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14572000 | USD |
CY2012Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
29201000 | USD |
CY2012Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
839000 | USD |
CY2012Q4 | us-gaap |
Due From Related Parties Current
DueFromRelatedPartiesCurrent
|
75000 | USD |
CY2012Q4 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
372000 | USD |
CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
95000 | USD |
CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
692000 | USD |
CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
48955000 | USD |
CY2012Q4 | us-gaap |
Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
|
252000 | USD |
CY2013Q2 | us-gaap |
Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
|
0 | USD |
us-gaap |
Restructuring And Related Cost Cost Incurred To Date
RestructuringAndRelatedCostCostIncurredToDate
|
877000 | USD | |
CY2012Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
0 | USD |
dei |
Entity Registrant Name
EntityRegistrantName
|
METABOLIX, INC. | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001121702 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-06-30 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
CY2013Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
34516762 | shares |
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | ||
CY2012Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
594000 | USD |
CY2012Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
2508000 | USD |
CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1233000 | USD |
CY2012Q4 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
165000 | USD |
CY2012Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
1067000 | USD |
us-gaap |
Revenue From Grants
RevenueFromGrants
|
839000 | USD | |
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
387000 | USD | |
mblx |
License And Royalty Revenue
LicenseAndRoyaltyRevenue
|
134000 | USD | |
CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5984000 | USD |
CY2012Q4 | us-gaap |
Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
|
55000 | USD |
CY2012Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
131000 | USD |
CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
6170000 | USD |
CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
343000 | USD |
CY2013Q2 | mblx |
License And Royalty Revenue
LicenseAndRoyaltyRevenue
|
62000 | USD |
mblx |
Research And Development Revenue
ResearchAndDevelopmentRevenue
|
618000 | USD | |
CY2013Q2 | mblx |
Research And Development Revenue
ResearchAndDevelopmentRevenue
|
238000 | USD |
us-gaap |
Revenue From Grants
RevenueFromGrants
|
1308000 | USD | |
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
1611000 | USD | |
CY2012Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
373000 | USD |
CY2012Q2 | mblx |
License And Royalty Revenue
LicenseAndRoyaltyRevenue
|
89000 | USD |
CY2013Q2 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
584000 | USD |
CY2013Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
822000 | USD |
CY2012Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
289050000 | USD |
CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-21000 | USD |
CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-242032000 | USD |
CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
47340000 | USD |
CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
53510000 | USD |
CY2013Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11908000 | USD |
CY2013Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
19770000 | USD |
CY2013Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
336000 | USD |
CY2013Q2 | us-gaap |
Unbilled Contracts Receivable
UnbilledContractsReceivable
|
819000 | USD |
CY2013Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
884000 | USD |
CY2013Q2 | us-gaap |
Assets Current
AssetsCurrent
|
36913000 | USD |
CY2013Q2 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
619000 | USD |
CY2013Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
95000 | USD |
CY2013Q2 | us-gaap |
Assets
Assets
|
38714000 | USD |
CY2013Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
102000 | USD |
CY2013Q2 | us-gaap |
Deferred Rent Credit Current
DeferredRentCreditCurrent
|
138000 | USD |
CY2013Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
529000 | USD |
CY2013Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3980000 | USD |
CY2013Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
137000 | USD |
CY2013Q2 | us-gaap |
Liabilities
Liabilities
|
4117000 | USD |
CY2013Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2013Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
CY2013Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
345000 | USD |
CY2013Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
290971000 | USD |
CY2013Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-59000 | USD |
CY2013Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-256660000 | USD |
CY2013Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
34597000 | USD |
CY2013Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
38714000 | USD |
CY2012Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2012Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2012Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2012Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
34306570 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
34306570 | shares |
CY2013Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2013Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2013Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2013Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2013Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2013Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2013Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
34451328 | shares |
CY2013Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
34451328 | shares |
CY2012Q2 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
461000 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
20866000 | USD | |
us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
492000 | USD | |
mblx |
Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
|
11051000 | USD | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
7836000 | USD | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
19379000 | USD | |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-5000 | USD | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-38000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2083000 | USD | |
us-gaap |
Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
|
-311000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-203000 | USD | |
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-18000 | USD | |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
21277000 | USD |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
75000 | USD | |
us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1753000 | USD | |
mblx |
Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
|
9802000 | USD | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6734000 | USD | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
18289000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14641000 | USD | |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
33000 | USD | |
CY2012Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
437000 | USD |
CY2012Q2 | mblx |
Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
|
5006000 | USD |
CY2012Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3437000 | USD |
CY2012Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
8880000 | USD |
CY2012Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7957000 | USD |
CY2013Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1196000 | USD |
CY2013Q2 | mblx |
Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
|
4945000 | USD |
CY2013Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3422000 | USD |
CY2013Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
9563000 | USD |
CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7857000 | USD |
CY2013Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
12000 | USD |
CY2012Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
34000 | USD |
CY2013Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.23 | |
CY2013Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.23 | |
CY2012Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.23 | |
CY2012Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.23 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.43 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.43 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.61 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.61 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-18000 | USD | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-23000 | USD | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
20869000 | USD | |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-11000 | USD | |
us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-27000 | USD | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-14666000 | USD | |
CY2012Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-5000 | USD |
CY2012Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-7000 | USD |
CY2012Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-12000 | USD |
CY2012Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7960000 | USD |
CY2013Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-4000 | USD |
CY2013Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-12000 | USD |
CY2013Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-16000 | USD |
CY2013Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7882000 | USD |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
718000 | USD | |
mblx |
Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
|
264000 | USD | |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
362000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
2821000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
101000 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-675000 | USD | |
mblx |
Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
|
-78000 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-38562000 | USD | |
us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
446000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-18143000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
287000 | USD | |
us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
47935000 | USD | |
us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
57207000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
8985000 | USD | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
19000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
19000 | USD | |
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-6000 | USD | |
us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-9145000 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
531000 | USD | |
mblx |
Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
|
268000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1677000 | USD | |
us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-503000 | USD | |
us-gaap |
Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
|
-75000 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
263000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
192000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1131000 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-345000 | USD | |
mblx |
Increase Decrease In Deferred Rent And Other Long Term Liabilities
IncreaseDecreaseInDeferredRentAndOtherLongTermLiabilities
|
-76000 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-538000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-14294000 | USD | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
270000 | USD | |
us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
10580000 | USD | |
us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
22509000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
11634000 | USD | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
14000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
14000 | USD | |
us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-2664000 | USD | |
CY2012Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
12132000 | USD |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.85 | pure | |
CY2013Q2 | us-gaap |
Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
|
1000 | USD |
us-gaap |
Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
|
217000 | USD | |
us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
25000 | USD | |
CY2013Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-21000 | USD |
CY2012Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-25000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-20000 | USD | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-49000 | USD | |
CY2013Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-9000 | USD |
CY2012Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
9000 | USD |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
13000 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
26000 | USD | |
CY2013Q2 | mblx |
Inventory Obsolescence For Raw Material And Finished Goods
InventoryObsolescenceForRawMaterialAndFinishedGoods
|
271000 | USD |